Andrea Antinori

机构：Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Center for Prevention and Treatment of Infections, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0003-2121-4684

发表论文 1086 篇 · 总被引 37273 次 · h-index 87

代表论文

• Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort (2025 · Journal of Antimicrobial Chemotherapy · 被引 15)
• HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study (2025 · Open Forum Infectious Diseases · 被引 13)
• Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 (2025 · Eurosurveillance · 被引 7)
• All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort (2025 · Open Forum Infectious Diseases · 被引 5)
• Improved HIV-1 Subtyping Accuracy Using near Full-Length Sequencing: A Comparison of Common Tools (2025 · International Journal of Molecular Sciences · 被引 4)
• Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies (2025 · Infectious Diseases and Therapy · 被引 4)